Date | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) | Price to Book Ratio (P/B) |
---|
CEO | Dr. Kevin J. Knopp Ph.D. |
IPO Date | Dec. 18, 2020 |
Location | United States |
Headquarters | 645 Summer Street |
Employees | 230 |
Sector | Health Care |
Industries |
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Past 5 years
USD 2.47
USD 67.79
USD 16.07
USD 79.17
USD 71.04
USD 362.80
USD 3.70
USD 113.02
USD 85.25
USD 79.30
USD 95.65
USD 147.95
USD 3.37
StockViz Staff
January 16, 2025
Any question? Send us an email